MTCH
59
9
TDC
70
3
O
33
2
WDC
70
2
GILD
56
6
AES
47
-3
AON
62
-5
ETN
55
2
MA
55
4
AIG
77
2
HAL
50
2
APA
53
5
TRIP
49
2
QCOM
45
2
MHK
43
-2
VTR
67
-3
DTE
38
-4
LRCX
62
6
KO
44
-2
INTU
60
-3
MTCH
59
9
TDC
70
3
O
33
2
WDC
70
2
GILD
56
6
AES
47
-3
AON
62
-5
ETN
55
2
MA
55
4
AIG
77
2
HAL
50
2
APA
53
5
TRIP
49
2
QCOM
45
2
MHK
43
-2
VTR
67
-3
DTE
38
-4
LRCX
62
6
KO
44
-2
INTU
60
-3
Financhill
Back

ZyVersa Therapeutics, Inc. 10K Form

Sell
49

ZVSA
ZyVersa Therapeutics, Inc.

Last Price:
$0.14
Seasonality Move:
-20.68%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ZVSA News And Ratings

See the #1 stock for the next 7 days that we like better than ZVSA

ZVSA Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-1.4M
Price / Cash Flow: 0
Annual Sales: $-1.45
Price / Book: 0.19

Profitability

EPS (TTM): -5.05430
Net Income (TTM): $-25.7M
Gross Margin: $-6.9K
Return on Equity: -711.85%
Return on Assets: -157.27%

ZyVersa Therapeutics, Inc. Earnings Forecast

Key ZyVersa Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 5 years have been positive in 2 years.

ZyVersa Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: ZVSA
Website: zyversa.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0.08
Quick Ratio: 0.04

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ZVSA Technical Analysis vs Fundamental Analysis

Sell
49
ZyVersa Therapeutics, Inc. (ZVSA) is a Sell

Is ZyVersa Therapeutics, Inc. a Buy or a Sell?